openPR Logo
Press release

Innovating Health: Unraveling the Impact of Advanced Technologies in the Cardiometabolic Diseases Market|| Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG

Cardiometabolic Diseases Market

Cardiometabolic Diseases Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Cardiometabolic Diseases Global Market Report 2023 identifies the high rate of obesity is expected to propel the growth of the cardiometabolic disease market going forward. Obesity is a complex condition characterized by the excessive accumulation of body fat, leading to higher body weight. Obesity directly influences the occurrence of cardiovascular risk factors such as dyslipidemia, type 2 diabetes, hypertension, and sleep problems. For instance, in March 2022, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, over 1 billion individuals are affected by obesity globally, which included 340 million teenagers, 650 million adults, and 39 million kids each year.

The global cardiometabolic diseases market size is expected to grow from $101.59 billion in 2022 to $106.30 billion in 2023 at a compound annual growth rate (CAGR) of 4.64%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of cardiometabolic diseases market is expected to reach $123.28 billion in 2027 at a CAGR of 3.77%.

Download Free Sample Of Cardiometabolic Diseases Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=11929&type=smp

Major competitors in the cardiometabolic diseases market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Kowa Company Ltd., Thermo Fisher Scientific, Abbott Laboratories, Takeda Pharmaceutical Company, Eli Lilly and Company, Novo Nordisk A/S, Siemens Healthineers, Boehringer Ingelheim International GmbH, Becton, Dickinson and Company.

A key trend in the cardiometabolic diseases market includes adoption of advanced technologies is a key trend gaining popularity in the cardiometabolic diseases market. Companies involved in the market for cardiometabolic diseases are working on adopting novel technologies to sustain their position in the market. For instance, in February 2023, Eko Health Inc., a US-based inventor of heart and lung disease-detecting digital health technologies, launched the Sensora cardiac disease detection platform. It includes artificial intelligence (AI) that reliably detects structural murmurs, a symptom of valvular heart disease (VHD), and care pathway analytics software that provides metrics and downstream insight into the patient journey through the healthcare system.

Read More On The Global Cardiometabolic Diseases Market Report Here: https://www.thebusinessresearchcompany.com/report/cardiometabolic-diseases-global-market-report

The cardiometabolic diseases market is segmented -

1) By Type: Chronic/Congestive Heart Failure, Hypertension, Type 2 Diabetes, Obesity

2) By Treatment: ACE inhibitors, Diuretics, Glucophage, Liposuction, Other Treatments

3) By Dosage: Tablet, Injection

4) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

5) By End-Users: Clinic, Hospital, Other End-Users

6) By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the cardiometabolic diseases market.

The Business Research Company's "Global Cardiometabolic Diseases Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Cardiometabolic Diseases Market Report Here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11929

The Table Of Content For The Cardiometabolic Diseases Market Include:
1. Executive Summary
2. Cardiometabolic Diseases Market Characteristic
3. Cardiometabolic Diseases Market Trends And Strategies
4. Cardiometabolic Diseases Market - Macro Economic Scenario
5. Cardiometabolic Diseases Market Size And Growth
……………
27. Cardiometabolic Diseases Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Cardiometabolic Diseases Market
29. Cardiometabolic Diseases Market Future Outlook And Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Innovating Health: Unraveling the Impact of Advanced Technologies in the Cardiometabolic Diseases Market|| Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG here

News-ID: 3304763 • Views:

More Releases from The Business research company

Global Fuel Cell Electric Vehicle Market Outlook 2025-2034: Growth Acceleration, Market Share Insights & Key Trend Breakdown
Global Fuel Cell Electric Vehicle Market Outlook 2025-2034: Growth Acceleration, …
The fuel cell electric vehicle report outlines and analyzes the fuel cell electric vehicle market, covering the historic period 2019-2024 and the forecast periods 2024-2029 and 2034F. The report assesses the market across regions and the major economies within each region. The global fuel cell electric vehicle market was valued at $2.26498 billion in 2024, increasing at a CAGR of 6.88% since 2019. The market is projected to rise from $2.26498
Global HR Advisory Services Market Set for 4.27% Growth, Projected to Reach $191.9 Billion by 2029
Global HR Advisory Services Market Set for 4.27% Growth, Projected to Reach $191 …
The HR advisory services report outlines and analyzes the HR advisory services market across 2019-2024 (historic period) and 2024-2029, 2034F (forecast period). It examines market performance across global regions and key economies. The global HR advisory services market was valued at approximately $155.73925 billion in 2024, increasing at a CAGR of 4.22% since 2019. The market is anticipated to rise from $155.73925 billion in 2024 to $191.94205 billion in 2029, reflecting
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancing Geophysical Surveys With Drones For Efficiency In Harsh Environments
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period? The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since

All 5 Releases


More Releases for Cardiometabolic

Cardiometabolic Disease Market to Reach $60.81B by 2035
Cardiometabolic Disease Market Poised for Steady Growth Amid Rising Global Health Concerns Tackling the Global Cardiometabolic Health Crisis Cardiometabolic diseases-including obesity, type 2 diabetes, hypertension, and chronic heart failure-represent a major global health challenge, contributing to morbidity, mortality, and escalating healthcare costs. These interlinked conditions share common risk factors such as sedentary lifestyle, unhealthy diets, and aging populations, creating a pressing need for effective preventive and therapeutic interventions. The global cardiometabolic disease market
Rising Obesity Rates Fuel Growth In Cardiometabolic Disease Market: Powering Inn …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Cardiometabolic Diseases Market Through 2025? The valuation of the cardiometabolic diseases sector has experienced consistent expansion over the last several years, projected to climb from $111.64 billion in 2024 up to $115.27 billion the following year, reflecting a 3.3% compound annual growth
Charting a New Era in Cardiometabolic Care: The Global Cardiometabolic Drug Mark …
In an era defined by rising rates of obesity, diabetes, and cardiovascular disease, the global cardiometabolic drug market has emerged as a cornerstone of modern healthcare. Spanning therapies for type 2 diabetes, dyslipidemia, hypertension, and related metabolic disorders, this market is not only addressing some of the world's most pressing health challenges but is also redefining standards of patient care through precision targeted medicines, innovative delivery systems, and breakthrough combination
Rising Obesity Rates Fuel Growth In Cardiometabolic Disease Market: Key Factor D …
The Cardiometabolic Diseases Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Cardiometabolic Diseases Market Size During the Forecast Period? The Cardiometabolic Diseases Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This
Cardiometabolic Diseases Market Embraces Advanced Solutions Trend: A Crucial Inf …
What industry-specific factors are fueling the growth of the cardiometabolic diseases market? The cardiometabolic disease market is projected to grow due to the anticipated rise in obesity rates. Being a multifaceted disorder, obesity is identified by an overly excessive accumulation of fat in the body, resulting in increased body weight. This directly impacts the occurrence of cardiovascular risk determinants such as dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. For example,
Cardiometabolic Diseases Market Analysis & Opportunities 2024-2033
"The Business Research Company recently released a comprehensive report on the Global Cardiometabolic Diseases Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample